Recent Quotes

My Watchlist

Indicators

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

32.54 +2.62 (+8.76%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,758,905
Open	30.33
Bid (Size)	32.33 (1,000)
Ask (Size)	32.60 (1,000)
Prev. Close	29.92
Today's Range	30.33 - 33.29
52wk Range	18.92 - 43.15
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More ↗

Today 7:58 EDT

There are some tempting bargains if you know where to look.

Via The Motley Fool

1 Reason This Biotech Stock Could Triple Before Year-End ↗

March 29, 2026

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

Via The Motley Fool

Performance

YTD	-8.1%	-8.1%
1 Month	-2.4%	-2.4%
3 Month	-10.8%	-10.8%
6 Month	+26.1%	+26.1%
1 Year	+34.7%	+34.7%

More News

Why Viking Therapeutics Stock Could Take Off Later This Year ↗

March 23, 2026

Via The Motley Fool

Goldman Sachs Bullish Forecast: 15% Increase in 2026 U.S. M&A Activity

March 23, 2026

Via MarketMinute

Small-Cap Resilience: Russell 2000 Surges 3% as Geopolitical Tensions Ease and ‘Risk-On’ Appetite Returns

March 23, 2026

Via MarketMinute

Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? ↗

March 22, 2026

Via The Motley Fool

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics ↗

March 17, 2026

Via The Motley Fool

What to Know About This Obesity Drug Developer That Just Drew a New $7 Million Investment ↗

March 16, 2026

Via The Motley Fool

3 Companies at the Forefront of the GLP-1 Pill Wars ↗

March 16, 2026

Via MarketBeat

Here's Why Viking Therapeutics Stock Recovered and Can Soar 2026 ↗

March 11, 2026

Via The Motley Fool

VKTX Stock Extends Red-Hot Streak: Insider Scoops Up Shares As Multiple Phase 3 Trials Loom This Year In Obesity Race ↗

March 11, 2026

Via Stocktwits

The Great Rotation: Russell 2000 Surges as Investors Flee Overstretched Tech Giants

March 10, 2026

Via MarketMinute

Viking CEO Sees Its Obesity Drug Beating Novo's Wegovy In Weight Loss ↗

March 10, 2026

Via Stocktwits

The $1.35 Trillion Wall: Why Small-Caps are Faltering as the S&P 500 Defies Gravity

March 09, 2026

Via MarketMinute

Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street ↗

March 09, 2026

Via The Motley Fool

The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026

February 27, 2026

Via Finterra

Viking Therapeutics: The High-Stakes Weight Loss Contender ↗

February 26, 2026

Via MarketBeat

Eli Lilly Just Took 2 Major Steps Forward in the Billion-Dollar Obesity Drug Market. Here's What You Need to Know. ↗

February 25, 2026

Via The Motley Fool

Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making. ↗

February 23, 2026

Via The Motley Fool

Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial

February 23, 2026

Via MarketMinute

Why Viking Therapeutics Stock Is Up More Than 9% Today ↗

February 23, 2026

Via The Motley Fool

Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head

February 23, 2026

Via MarketMinute

Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial

February 23, 2026

Via MarketMinute

3 Reasons Viking Therapeutics Stock Could 10X if Its Obesity Pipeline Succeeds ↗

February 23, 2026

Via The Motley Fool

2 Innovative Biotech Stocks That May Climb 58% and 200%, According to Wall Street ↗

February 19, 2026

Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 32.54

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 03/31/26 04:00 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.24B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.